The Canadian Press - ONLINE EDITION

Colorado first state to approve experimental drugs for the terminally ill

  • Print

DENVER - Nick Auden didn't live to see the legislation, but the case of the Denver melanoma patient who died while seeking access to an experimental drug helped inspire a first-of-its kind law in Colorado.

The "Right To Try" law allows terminally ill patients to obtain experimental drugs without getting federal approval. It's a proposal being advanced in several states by patient advocates who are frustrated by the yearslong federal approval process for experimental drugs in the pipeline.

"There are experimental drugs out there that can and do save lives, and access needs to be expanded," said Auden's widow, Amy Auden of Lone Tree, Colorado. Nick Auden died in November at age 41 after unsuccessfully lobbying two drug companies to use an experimental treatment outside of clinical trials. Auden had acknowledged there was no guarantee the drug would work.

Gov. John Hickenlooper on Saturday signed Colorado's "Right To Try" bill, which was passed unanimously in the state Legislature.

Similar bills await governors' signatures in Louisiana and Missouri, and Arizona voters will decide in November whether to set up a similar program in that state.

Supporters call it a ray of hope for dying patients trying to navigate the red tape of existing "compassionate use" guidelines for obtaining drugs outside clinical trials. The process requires federal approval.

"When you're terminal and there's a drug out there that might help you, it can seem that the obstacles to get that drug are insurmountable," said state Sen. Irene Aguilar, a physician who co-sponsored Colorado's bill.

Aguilar dubbed the measure the "Dallas Buyers Club" bill, after the movie about a determined AIDS patient who smuggled treatments from Mexico because they weren't cleared for use in the U.S.

But skeptics call "Right To Try" a feel-good campaign that won't help dying patients.

The law doesn't require drug companies to provide any drug outside federal parameters, and there's no indication pharmaceutical companies will do so.

A 2003 lawsuit to force the U.S. Food and Drug Administration to expand the availability of investigational drugs failed. A federal judge disagreed that terminally ill people have a right to access to investigational medicine, and the U.S. Supreme Court declined to consider an appeal.

State-level approaches are an effort to circumvent the federal system, but critics say they won't work.

"The FDA regulates drug development, and this doesn't do anything to change that," said Dr. David Gorski, a surgical oncologist and editor of the blog Science Based Medicine.

Gorski said a drug company "wouldn't do anything to endanger a drug they're potentially spending hundreds of millions of dollars to bring to market" through elaborate FDA trials.

Colorado's bill got a careful no-comment from state doctors' groups, hospitals and health insurers. The bill was amended to clarify that health care providers and insurers aren't liable if a patient who uses a drug outside clinical trials gets sick or dies.

Supporters insist the states should push the envelope on clinical trials to speed up the work of federal drug regulators.

"It's so basic, the right to fight for your own life," said Darcy Olsen, president of the Phoenix-based Goldwater Institute, a conservative think-tank that promotes "Right To Try" legislation in state legislatures.

___

Kristen Wyatt can be reached at http://www.twitter.com/APkristenwyatt

___

Online:

House Bill 1281: http://goo.gl/U0OWi3

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes

    No

  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Glenn January won't blame offensive line for first loss

View more like this

Photo Store Gallery

  • Marc Gallant/Winnipeg Free Press. Local- Peregrine Falcon Recovery Project. Baby peregrine falcons. 21 days old. Three baby falcons. Born on ledge on roof of Radisson hotel on Portage Avenue. Project Coordinator Tracy Maconachie said that these are third generation falcons to call the hotel home. Maconachie banded the legs of the birds for future identification as seen on this adult bird swooping just metres above. June 16, 2004.
  • Two Canadian geese perch themselves for a perfect view looking at the surroundings from the top of a railway bridge near Lombard Ave and Waterfront Drive in downtown Winnipeg- Standup photo- May 01, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)

View More Gallery Photos

Poll

Should Winnipeg control growth to deal with climate change?

View Results

View Related Story

Ads by Google